Correlation Between Purple Biotech and Purple Biotech

Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Purple Biotech and Purple Biotech, you can compare the effects of market volatilities on Purple Biotech and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Purple Biotech.

Diversification Opportunities for Purple Biotech and Purple Biotech

1.0

Correlation Coefficient

Purple Biotech  Purple Biotech

No risk reduction

The 3 months correlation between Purple and Purple is 1.0. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Purple Biotech i.e., Purple Biotech and Purple Biotech go up and down completely randomly.

Pair Corralation between Purple Biotech and Purple Biotech

Assuming the 90 days trading horizon Purple Biotech is expected to generate 0.96 times more return on investment than Purple Biotech. However, Purple Biotech is 1.04 times less risky than Purple Biotech. It trades about 0.03 of its potential returns per unit of risk. Purple Biotech is currently generating about 0.02 per unit of risk. If you would invest  1,570  in Purple Biotech on September 4, 2024 and sell it today you would lose (280.00) from holding Purple Biotech or give up 17.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Purple Biotech  vs.  Purple Biotech

Purple Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Purple Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Purple Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Purple Biotech

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Purple Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Purple Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Purple Biotech and Purple Biotech

The main advantage of trading using opposite Purple Biotech and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.

The idea behind Purple Biotech and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.